2022
DOI: 10.3390/diagnostics12071645
|View full text |Cite
|
Sign up to set email alerts
|

Gestational Diabetes Melitus and Cord Blood Platelet Function Studied via the PFA-100 System

Abstract: Neonatal platelet hemostasis, although it has been well described over the recent years, remains elusive in specific patient populations, including neonates from high-risk pregnancies, such as those complicated with gestational diabetes mellitus (GDM). We aimed at evaluating the platelet function of neonates born to mothers with GDM using the platelet function analyzer (PFA-100). Cord blood samples were drawn from each subject and tested with two different agonists to provide two closure time (CT) values (coll… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 54 publications
(56 reference statements)
0
1
0
Order By: Relevance
“…The PFA-100 has been extensively evaluated in a variety of physiological and pathological conditions in more than 1,000 publications, including platelet function defects such as the von Willebrand disease, surgical bleeding risk, as well as stroke and myocardial ischemia, and venous thrombosis risk [19,20]. PFA-100 has also been used to assess platelet function in normal pregnant women and in high-risk pregnancies, such as those complicated by preeclampsia and gestational diabetes mellitus [21][22][23]. Additionally, two recent publications reported prolonged COL/EPI CT in healthy preterm neonates [24] and in those born with fetal growth restriction [25].…”
Section: Discussionmentioning
confidence: 99%
“…The PFA-100 has been extensively evaluated in a variety of physiological and pathological conditions in more than 1,000 publications, including platelet function defects such as the von Willebrand disease, surgical bleeding risk, as well as stroke and myocardial ischemia, and venous thrombosis risk [19,20]. PFA-100 has also been used to assess platelet function in normal pregnant women and in high-risk pregnancies, such as those complicated by preeclampsia and gestational diabetes mellitus [21][22][23]. Additionally, two recent publications reported prolonged COL/EPI CT in healthy preterm neonates [24] and in those born with fetal growth restriction [25].…”
Section: Discussionmentioning
confidence: 99%